Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
654
datasets available to search
ShareScore release 0.9.0
Dataset results
654 results for “estrogen receptor”
DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)
ClinicalTrials.gov study NCT04567420. IPD Sharing: NO. Countries: 1. Publications: 0.
Estrogen Receptor Beta Agonists (Eviendep) and Polyp Recurrence
ClinicalTrials.gov study NCT01402648. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor Status
ClinicalTrials.gov study NCT01916122. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2
ClinicalTrials.gov study NCT04052555. IPD Sharing: YES. Countries: 1. Publications: 0.
Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer
ClinicalTrials.gov study NCT00077025. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-P
ClinicalTrials.gov study NCT07214662. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive
ClinicalTrials.gov study NCT07100106. IPD Sharing: YES. Countries: 5. Publications: 0.
Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer
ClinicalTrials.gov study NCT00498901. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of GDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT02316509. IPD Sharing: Not stated. Countries: 2. Publications: 0.
The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study
ClinicalTrials.gov study NCT00206557. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzuma
ClinicalTrials.gov study NCT03619044. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT00093002. IPD Sharing: Not stated. Countries: 6. Publications: 0.
[99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression
ClinicalTrials.gov study NCT07275463. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients
ClinicalTrials.gov study NCT01278810. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HE
ClinicalTrials.gov study NCT05306340. IPD Sharing: YES. Countries: 13. Publications: 0.
Estrogen Receptors and HER2 Levels' Expression in Luminal Metastatic Breast Cancer
ClinicalTrials.gov study NCT06243432. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy
ClinicalTrials.gov study NCT03281902. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Re
ClinicalTrials.gov study NCT00077168. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer
ClinicalTrials.gov study NCT02599714. IPD Sharing: YES. Countries: 2. Publications: 0.
A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/M
ClinicalTrials.gov study NCT04572295. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.